← Evidence map

ArticleClinical and molecular hepatology2024

Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations.

Xinyi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38163440